The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Yanchenko S.V.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Hamroev B.G.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Malyshev A.V.

Maykop State Technological University, Maykop, Adygea;
Scientific Research Institution — S.V. Ochapovsky Regional Clinical Hospital No. 1, Krasnodar, Russia

Teshaev Sh.J.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Kharibova E.A.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Odilova G.R.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Davlatov S.S.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Bekmurodova O.K.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Dry eye disease in young and middle-aged adults

Authors:

Yanchenko S.V., Hamroev B.G., Malyshev A.V., Teshaev Sh.J., Kharibova E.A., Odilova G.R., Davlatov S.S., Bekmurodova O.K.

More about the authors

Journal: Russian Annals of Ophthalmology. 2026;142(1): 112‑122

DOI: 10.17116/oftalma2026142011112

Read: 621 times

Buy for 300₽
Contact the author
Table of contents

DRY EYE DISEASE IN YOUNG AND MIDDLE-AGED ADULTS
DRY EYE DISEASE IN YOUNG AND MIDDLE-AGED ADULTS

To cite this article:

Yanchenko SV, Hamroev BG, Malyshev AV, et al. Dry eye disease in young and middle-aged adults. Russian Annals of Ophthalmology. 2026;142(1):112‑122. (In Russ.)
https://doi.org/10.17116/oftalma2026142011112

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
Prevalence of postpartum depression in the Russian Fede­ration: a systematic review and meta-analysis. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):74-87
Contribution of the Russian Academy of Sciences Academician R.G. Oganov to the deve­lopment of the dome­stic preventive cardiology. Russian Journal of Preventive Medi­cine. 2025;(6):7-10
Risk factors for low back pain in healthcare professionals taking care for patients with redu­ced mobi­lity. Russian Journal of Preventive Medi­cine. 2025;(7):75-80
Epidemiology and prevention of prostate cancer. Russian Journal of Preventive Medi­cine. 2025;(7):111-118
Ethnic aspe­cts of risk factors for the type 2 diabetes mellitus deve­lopment in the overweight women of the Pribaikalsky region. Russian Journal of Preventive Medi­cine. 2025;(8):56-62
Clinical features of myocardial infa­rction in young patients. Part 1. The stru­cture of risk factors, pathogenesis and clinical presentation. Russian Journal of Preventive Medi­cine. 2025;(8):63-69
Cere­bral venous thro­mbosis in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):11-19
Epileptogenesis and risk factors of symptomatic epileptic seizures in patients with acute cere­brovascular acci­dents. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):26-31
Sex and age characteristics of stroke risk factors in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):89-97
Abstract:

According to publications from 2016—2025, the prevalence of dry eye disease (DED) based on the assessment of clinical signs and symptoms in young and middle-aged adults may exceed 30.8—41.43%, while based on symptoms the prevalence ranges from 41.5% to 55%, highlighting the need for further evaluation and investigation. In these age groups, evaporative DED (DEWS II criteria), corresponding to hypersecretory DED, is more commonly diagnosed. One of its major risk factors is computer vision syndrome, which leads to increased tear film evaporation due to reduced blink rate, an increased number of incomplete blinks, and the development of meibomian gland dysfunction (MGD). Other DED risk factors may include exogenous and systemic stimuli, as well as changes of the ocular surface, including MGD. This article presents an analysis of data on the epidemiology and clinical features of DED in young and middle-aged adults, as well as potential therapeutic strategies, including elimination of modifiable risk factors, differentiated tear replacement therapy, anti-inflammatory treatment, and eyelid hygiene, including the use of Blepharogel Ochischenie cleansing gel, Blepharolosion lotion, Blepharosalfetka wipes, Blepharogel 1, Blepharogel 2, and Blepharogel Forte.

Keywords:

dry eye disease
young age
middle age
risk factors
computer vision syndrome
meibomian gland dysfunction
eyelid hygiene

Authors:

Yanchenko S.V.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Hamroev B.G.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Malyshev A.V.

Maykop State Technological University, Maykop, Adygea;
Scientific Research Institution — S.V. Ochapovsky Regional Clinical Hospital No. 1, Krasnodar, Russia

Teshaev Sh.J.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Kharibova E.A.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Odilova G.R.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Davlatov S.S.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Bekmurodova O.K.

Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan

Received:

02.09.2025

Accepted:

13.11.2025

Close metadata

References:

  1. Papas E.B. The global prevalence of dry eye disease: A Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254-1266. https://doi.org/10.1111/opo.12888
  2. Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, de Paiva CS, Gomes JAP, Hammit KM, Jones L, Nichols JJ, Nichols JS, Novak GD, Stapleton F, Wilcox MDP, Wolffsohn JS, Sullivan DA TFOS DEWS II Report Executive Summary. Ocular Surface. 2017;15(4):802-812.  https://doi.org/10.1016/j.jtos.2017.08.003
  3. Gavrilova TV, Kozitsyna DD, Misheneva OA. Experience in the Treatment of Dry Eye Syndrome in Students with Myopic Refraction. Ophthalmology in Russia. 2023;20(3):536-541. (In Russ.). https://doi.org/10.18008/1816-5095-2023-3-536-541
  4. Drozdova EA, Berdnikova EV, Dashenko DM. Risk factors, clinical features and indications for treatment of dry eye disease at a young age. Russian Annals of Ophthalmology. 2023;139(6):94-100. (In Russ.). https://doi.org/10.17116/oftalma202313906194
  5. Klokova OA, Damashauskas RO, Geidenrich MS. Ocular surface treatment in dry eye patients before corneal refractive surgery. Russian Journal of Clinical Ophthalmology. 2020;20(4):180-186. (In Russ.). https://doi.org/10.32364/2311-7729-2020-20-4-180-186
  6. Maychuk DY. Prevalence and severity of dry eye in candidates for laser in situ keratomileusis for myopia in Russia. J Cataract Refract Surg. 2016:42:427-434.  https://doi.org/10.1016/j.jcrs.2015.11.038
  7. Onufriichuk ON, Kuroyedov AV. Prevalence of dry eye disease in Russia. Russian Journal of Clinical Ophthalmology. 2021;21(2):96-102. (In Russ). https://doi.org/10.32364/2311-7729-2021-21-2-96-102
  8. Sakhnov SN, Yanchenko SV, Malyshev AV. et al. Dry eye epidemiology in patients before refractive operations. Ophthalmology in Russia. 2018:15(1): 92-101. (In Russ.). https://doi.org/10.18008/1816-5095-2018-1-92-101
  9. Aćimović L, Stanojlović S, Kalezić T. et al. Evaluation of dry eye symptoms and risk factors among medical students in Serbia. PLoS One. 2022;24; 17(10):e0275624. https://doi.org/10.1371/journal.pone.0275624
  10. Asiedu K, Kyei S, Boampong F. et al. Symptomatic Dry Eye and Its Associated Factors: A Study of University Undergraduate Students in Ghana. Eye Cont Lens. 2017;43(4):262-266.  https://doi.org/10.1097/ICL.0000000000000256
  11. Cartes C, Segovia C, Salinas-Toro D. et al. Traipe L. Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic. Ophthalmic Epidemiol. 2022;29(3):245-251.  https://doi.org/10.1080/09286586.2021.1943457
  12. Casemore RK, Wolffsohn JS, Utheim TP. et al. A prospective, longitudinal study to assess progression of ocular surface signs, tear cytokines and protein profiles in young adults. Ocul Surf. 2025;25;37:57-67.  https://doi.org/10.1016/j.jtos.2025.02.011
  13. Garza-León M, Valencia-Garza M, Martínez-Leal B. et al. Prevalence of ocular surface disease symptoms and risk factors in group of university students in Monterrey, Mexico. J Ophthal Inf Infect. 2016;6(1):44.  https://doi.org/10.1186/s12348-016-0114-z
  14. Li M, Zeng L, Mi S. et al. A Multicenter Study of the Prevalence of Dry Eye Disease in Chinese Refractive Surgery Candidates. Ophthalmic Res. 2021; 64(2):224-229.  https://doi.org/10.1159/000509060
  15. Lin F, Cai Y, Fei X. et al. Prevalence of dry eye disease among Chinese high school students during the COVID-19 outbreak. BMC Ophthalmol. 2022; 22(1):190.  https://doi.org/10.1186/s12886-022-02408-9
  16. Lulla NH, Loganathan M, Balan VGM. Dry eye among medical students before and during COVID-19. Indian J Ophthalmol. 2023;71(4):1468-1471. https://doi.org/10.4103/IJO.IJO_2786_22
  17. Luo CK, Tan QQ, Tea Y. et al. The prevalence of dry eye disease symptoms and its association with screen time in young adults aged 21-30 years. Ophthalmic Physiol Opt. 2025;45(5):1195-1200. https://doi.org/10.1111/opo.13505
  18. Preoteasa LD, Preoteasa D. Assessment of the prevalence and risk factors for dry eye symptoms among Romanian medical students using the ocular surface disease index — a cross-sectional study. BMC Ophthalmol. 2024; 5;24(1):12.  https://doi.org/10.1186/s12886-023-03260-1
  19. Tangmonkongvoragul C, Chokesuwattanaskul S, Khankaeo C. et al. Prevalence of symptomatic dry eye disease with associated risk factors among medical students at Chiang Mai University due to increased screen time and stress during COVID-19 pandemic. PLoS One. 2022;17(3):e0265733. https://doi.org/10.1371/journal.pone.0265733
  20. Wróbel-Dudzińska D, Osial N, Stępień PW. et al. Prevalence of Dry Eye Symptoms and Associated Risk Factors among University Students in Poland. Int J Environ Res Public Health. 2023;11;20(2):1313. https://doi.org/10.3390/ijerph20021313
  21. Yang I, Wakamatsu T, Sacho IBI. et al. Prevalence and associated risk factors for dry eye disease among Brazilian undergraduate students. PLoS One. 2021;16(11):e0259399. https://doi.org/10.1371/journal.pone.0259399
  22. Pokrovskiy VI., ed. Malaya meditsinskaya entsiklopediya. Vol. 1: M. 1991; 573 p. (In Russ).
  23. Diaz T, Strong KL, Cao B. et al. A call for standardised age-disaggregated health data. Lancet Healthy Longev. 2021;2(7):e436-e443. https://doi.org/10.1016/S2666-7568(21)00171-9
  24. Brzhesky VV, Egorova GB, Egorov EA. Dry eye and ocular surface diseases. GEOTAR-Media. 2016; 448 p. (In Russ).
  25. Barabino S. Is dry eye disease the same in young and old patients? A narrative review of the literature. BMC Ophthalmol. 2022;22(1):85.  https://doi.org/10.1186/s12886-022-02269-2
  26. Stapleton F, Alves M, Bunya VY. et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334-365.  https://doi.org/10.1016/j.jtos.2017.05.003
  27. Stapleton F, Velez FG, Lau C, Wolffsohn JS. Dry eye disease in the young: A narrative review. Ocul Surf. 2024;31:11-20.  https://doi.org/10.1016/j.jtos.2023.12.001
  28. Farrand KF, Fridman M, Stillman IÖ. et al. Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older. Am J Ophthalmol. 2017;182:90-98.  https://doi.org/10.1016/j.ajo.2017.06.033
  29. Vehof J, Snieder H, Jansonius N. et al. Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in the Netherlands. Ocul Surf. 2021;19:83-93.  https://doi.org/10.1016/j.jtos.2020.04.005
  30. Wolffsohn JS, Semp DA. et al. TFOS ambassadors. Clinical practice patterns in the management of dry eye disease: A TFOS international survey 2023-24. Ocul Surf. 2025:36:164-172.  https://doi.org/10.1016/j.jtos.2024.12.008
  31. Yanchenko SV, Odilov MYu, Kharibova EA. et al. Differentiated approaches to correcting the condition of the ocular surface in dry eye syndrome: a literature review. Russian Journal of Clinical Ophthalmology. 2025;25(2):109-116 (In Russ.). https://doi.org/10.32364/2311-7729-2025-25-2-5
  32. Sakhnov SN, Yanchenko SV, Malyshev AV. et al. Dry eye epidemiology in patients before cataract surgery. Ophthalmology in Russia. 2020;17(2):281-289. (In Russ.). https://doi.org/10.18008/1816-5095-2020-2-281-289
  33. Tsubota K, Yokoi N, Watanabe H. et al. Members of The Asia Dry Eye Society. A New Perspective on Dry Eye Classification: Proposal by the Asia Dry Eye Society. Eye Contact Lens. 2020:46 Suppl 1(1):2-13.  https://doi.org/10.1097/ICL.0000000000000643
  34. Yanchenko SV, Malyshev AV, Sakhnov SN. The choice of dry eye therapy depending on ocular surface condition. Ophthalmology in Russia. 2021;18(2): 346-354. (In Russ.). https://doi.org/10.18008/1816-5095-2021-2-346-354
  35. Wang MTM, Tien L, Han A. et al. Impact of blinking on ocular surface and tear film parameters. Ocul Surf. 2018;16(4):424-429.  https://doi.org/10.1016/j.jtos.2018.06.001
  36. Talens-Estarelles C, García-Marqués JV, Cervino A. et al. Use of digital displays and ocular surface alterations: A review. Ocul Surf. 2021;19:252-265.  https://doi.org/10.1016/j.jtos.2020.10.001
  37. Fjaervoll H, Fjaervoll K, Magno M. et al. The association between visual display terminal use and dry eye: a review. Acta Ophthalmol. 2022;100(4): 357-375.  https://doi.org/10.1111/aos.15049
  38. Narang P, Donthineni PR, D’Souza S. et al. Evaporative dry eye disease due to meibomian gland dysfunction: Preferred practice pattern guidelines for diagnosis and treatment. Indian J Ophthalmol. 2023;71(4):1348-1356. https://doi.org/10.4103/IJO.IJO_2841_22
  39. Maity M, Galor A, Basu S. et al. Tear Film Dynamics in Visual Display Terminal Users: A Review of Impact on Goblet Cells, Lacrimal and Meibomian Gland Function. Semin Ophthalmol. 2025;40(4):306-319.  https://doi.org/10.1080/08820538.2024.2332355
  40. Wu H, Wang Y, Dong N. et al. Meibomian gland dysfunction determines the severity of the dry eye conditions in visual display terminal workers. PLoS One. 2014;9(8):e105575. https://doi.org/10.1371/journal.pone.0105575
  41. Wang X, Lu X, Yang J. et al. Evaluation of Dry Eye and Meibomian Gland Dysfunction in Teenagers with Myopia through Noninvasive Keratograph. J Ophthalmol. 2016;2016:6761206. https://doi.org/10.1155/2016/6761206
  42. Gomes JAP, Azar DT, Baudouin C. et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017;15:511-538. 
  43. Donthineni PR, Das AV, Basu S. Dry eye disease in children and adolescents in India. Ocul Surf. 2020;18(4):777-782.  https://doi.org/10.1016/j.jtos.2020.07.019
  44. Prabhasawat P, Chirapapaisan C, Chitkornkijsin C. Eyeliner Induces Tear Film Instability and Meibomian Gland Dysfunction. Cornea. 2020;39(4): 473-478.  https://doi.org/10.1097/ICO.0000000000002198
  45. Badian RA, Utheim TP, Chen X. et al. Meibomian gland dysfunction is highly prevalent among first-time visitors at a Norwegian dry eye specialist clinic. Sci Rep. 2021;11(1):23412. https://doi.org/10.1038/s41598-021-02738-6
  46. Yanchenko SV, Malyshev AV, Teshaev ShZh. et al. Efficacy and Safety of Chronic Blepharitis Treatment. Ophthalmology in Russia. 2023;20(4): 772-779. (In Russ.). https://doi.org/10.18008/1816-50952023-4-772-779
  47. Lee WJ, Kim M, Lee SH. et al. The varied influence of ocular Demodex infestation on dry eye disease and meibomian gland dysfunction across different age groups. Sci Rep. 2023;13(1):16324. https://doi.org/10.1038/s41598-023-43674-x
  48. Chen H, Mc Cann P, Lien T. et al. Prevalence of dry eye and Meibomian gland dysfunction in Central and South America: a systematic review and meta-analysis. BMC Ophthalmol. 2024;24(1):50.  https://doi.org/10.1186/s12886-023-03249-w
  49. Sabhahit SV, Babu M. Ocular effects of eye cosmetic formulations. Cutan Ocul Toxicol. 2024;43(3):154-160.  https://doi.org/10.1080/15569527.2024.2360735
  50. Sakhnov SN, Yanchenko SV, Malyshev AV. et al. Ocular surface changes in allergic blepharoconjunctivitis and dry eye syndrome: diagnosis and therapy possibilities. Russian ophthalmological journal. 2024;17(1):55-61. (In Russ.). https://doi.org/10.21516/2072-0076-2024-17-1-55-61
  51. Zhu L, Wang YH, Li SY. et al. Research on the impact of lid margin tattooing on the morphology and function of the ocular surface and meibomian glands. Zhonghua Yan Ke Za Zhi. 2025;61(2):96-103.  https://doi.org/10.3760/cma.j.cn112142-20240714-00300
  52. Jones L, Downie LE, Korb D. et al. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017;15:575-628.  https://doi.org/10.1016/j.jtos.2017.05.006
  53. Labetoulle M, Benitez-Del-Castillo JM, Barabino S. et al. Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease. Int J Mol Sci. 2022;23(5):2434. https://doi.org/10.3390/ijms23052434
  54. Neroev VV, Egorov EA, Moshetova LK. et al. Ophthalmology. National guide: M.: GEOTAR-Media; 2025. (In Russ.).
  55. Wang Da-Hu, Liu Xin-Quan, Hao Xiao-Jun et al. Effect of the Meibomian Gland Squeezer for Treatment of Meibomian Gland Dysfunction. Cornea. 2018;37(10):1270-1278. https://doi.org/10.1097/ICO.0000000000001682
  56. Rolando M., Merayo-Lloves J. Management Strategies for Evaporative Dry Eye Disease and Future Perspective. Curr Eye Res. 2022;47(6):813-823.  https://doi.org/10.1080/02713683.2022.2039205
  57. Makarov IA, Polunin GS, Kurenkov VV, Zabegailo AO, Safonova TN, et al. The efficacy of some physiotherapeutic and hygienic procedures for treatment of blepharoconjunctival form of dry eye. Ophthalmology in Russia. 2012;9(2):65-71. (In Russ.). https://doi.org/10.18008/1816-5095-2020-2-281-289
  58. Safonova TN, Kintyukhina NP, Petrenko AE. et al. Prevention of “dry eye” syndrome at chronic blepharitis of demodex etiology. RMJ. Clinical Ophthalmology. 2012;16(2): 89-93. (In Russ.).
  59. Trubilin VN, Polunina EG, Markova EYu. et al. Therapeutic hygiene of the eyelids in algorithms for the prevention and treatment of diseases of the eye surface. P. 1. Ophthalmology in Russia. 2016;13(2):122-127. (In Russ.). https://doi.org/10.18008/181650952016212212
  60. Sakhnov SN, Yanchenko SV, Malyshev AV. et al. Effectiveness and safety of demodecosis blepharitis therapy under dry eye conditions. Russian ophthalmological journal. 2024;17(2):32-37. (In Russ.). https://doi.org/10.21516/2072-0076-2024-17-2-32-37
  61. Yanchenko SV, Malyshev AV, Teshaev SJ, et al. Allergic seasonal blepharoconjunctivitis therapy optimization in conditions of dry eye and meibomian glands dysfunctions. Russian ophthalmological journal. 2025;18(1):76-83. (In Russ.). https://doi.org/10.21516/2072-0076-2025-18-1-76-83
  62. Lei Y, Peng J, Liu J. et al. Intense pulsed light (IPL) therapy for meibomian gland dysfunction (MGD)-related dry eye disease (DED): a systematic review and meta-analysis. Lasers Med Sci. 2022;19;38(1). https://doi.org/10.1007/s10103-022-03690-1
  63. Meduri A, Oliverio GW, Tedesco G. et al. Combined intense pulsed light and low-level light therapy for the treatment of refractory Meibomian gland dysfunction. Eur J Ophthalmol. 2022;13:728-734.  https://doi.org/10.1177/11206721221127206
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.